1 Most were issued on September 9, 2025, but the FDA continues to publish new letters
Circ Res 126(2):280293 Chen L, Shi D, Guo M (2021) The roles of PKC-delta and PKC-epsilon in myocardial ischemia/reperfusion injury
We believe in empowering our clients with knowledge, and our experienced healthcare professionals are dedicated to guiding you through these treatment options
Lumen helps you stay on track, build better habits, and get more from your GLP-1 shots
This isn't just inflation or trend, its a convergence of cost drivers - : 74% spike in $1M+ claims since 2021 - : providers are charging more : quietly adding 24% to premiums : GLP-1s and specialty drugs are reshaping budgets : demand is up, longer treatments, higher costs